Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread
about
sameAs
Molecular mechanism underlying lymphatic metastasis in pancreatic cancerMolecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tractAssessment of hepatic VX(2) tumors with combined percutaneous transhepatic lymphosonography and contrast-enhanced ultrasonographic imagingHigh-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cellsUltradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instabilityImpact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma.Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancerGastrointestinal lymphatics in health and diseaseMarkers of bile duct tumorsProx1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinomaIdentification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic AdenocarcinomaPROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.PROX1 gene is differentially expressed in oral cancer and reduces cellular proliferation.Lymphangiogenesis and biological behavior in pancreatic carcinoma and other pancreatic tumors.Impact of prospero homeobox-1 on tumor cell behavior and prognosis in colorectal cancerPotential therapeutic strategies for lymphatic metastasis.The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.Novel aspects of corneal angiogenic and lymphangiogenic privilege.The lymphatic system and pancreatic cancer.The impact of hypoxia in pancreatic cancer invasion and metastasis.Loss of HNF6 expression correlates with human pancreatic cancer progression.Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.The role of prospero homeobox 1 (PROX1) expression in follicular thyroid carcinoma cells.Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer.
P2860
Q26999345-821D7C62-6850-43BE-95A7-F0494EA5FE2FQ26999345-B7ECC358-73F3-4FB5-A457-6A0AC0812733Q27013620-7C2AF8B4-0CC0-4795-895E-FC6805DCDFD7Q27013620-AF17D47F-B01B-42A7-871D-3B5165FA3EFEQ30487612-15FE5664-308D-4771-86FF-F7B3AD6ADF38Q30487612-3003E27A-D411-407B-BE1A-D377E5D0A73BQ30502529-0945AB81-C843-4FBF-9BA9-91B525CC50C4Q30502529-1235D2C4-2DE9-47EF-9C62-4346D3C965C9Q33522197-3DFE2A0E-AF7B-4441-9B1F-38634FEC0B5CQ33522197-EDEC7C55-B293-42CC-BAB0-2CDEA674629EQ33567647-4DC0EF30-FDC4-4C3F-9064-5DC42A26CE18Q33567647-62BB621B-EAA8-417E-B2F2-208C4F033C2AQ34173290-127F2D8D-73B3-47D5-95A8-D89E4B5CA108Q34173290-22A54BAD-7491-4A19-BD90-3430CA46AB91Q34519124-503A39D2-9515-456D-8D35-EF0151E19EACQ34519124-639C2050-797B-40E8-9EFC-12D1EFC1D2E1Q34628852-24A78ED3-4CDB-4935-BB27-18B60A714486Q34628852-575AC9EF-805F-4B11-AC6C-533269BE17ABQ35125330-6A8475CC-502E-434F-845F-F20E5C48A6A3Q35125330-9714C94F-F383-47A5-A99A-013BF5BB616AQ35964357-1761CD83-1FDB-4551-9DC5-80BEB014318EQ35964357-87A2954D-9512-477C-9965-6AE5B78FC2B5Q36076312-492D331E-B965-4D8A-B21C-BDA7294EA019Q36076312-FE9E8B53-4263-40F2-BAFC-2B40D8C29EB8Q36153873-B69207D5-AAEA-4BD5-A5D2-40B2CE3F6ABAQ36153873-C7466D78-B2F9-470F-961A-EB1470726B6EQ36383098-9909EED6-B795-4100-9169-5E431EEEA9D9Q36383098-BF1CFC87-59F3-406F-BD9B-CF43099EF923Q36420135-79E863DD-13B5-4F9B-9723-08CC8D0F0AE5Q36420135-AA9BFDD7-1654-4A18-9217-EEC83BFB8D9EQ36851512-CA5CCDB6-A86F-4E33-B6BF-221F32815365Q36851512-E198ECB9-81A7-44E3-A666-4DC01D6FFCD8Q37381588-3DDC6B3B-3B2F-45B4-ADDC-6EED0A237769Q37381588-70721679-0450-4DEA-AE99-B90E49E9D44CQ37681157-241F205B-F9A1-4FA8-A215-DF5AE9D315DAQ37681157-83F62A97-56B1-4031-B51B-BA5B751C5F08Q38689578-048674E7-AFB0-4237-8B6A-AE73CBAA3F98Q38689578-832192C0-4704-4B61-9570-E812FB098657Q38989132-2A44436A-3996-4199-BC06-2F8844BFB013Q38989132-B38C2E7B-AE71-46E0-9B47-C040A670AD1A
P2860
Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@ast
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@en
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@nl
type
label
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@ast
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@en
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@nl
prefLabel
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@ast
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@en
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@nl
P2093
P50
P3181
P356
P1476
Role of lymphangiogenesis and ...... ogression and lymphatic spread
@en
P2093
Jörg Wilting
Martin Schneider
Peter Büchler
Thomas Giese
P304
P3181
P356
10.3892/IJO.28.4.883
P407
P577
2006-04-01T00:00:00Z